Publications

5808 Results

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)

Authors
S Lee;S Zhang;F-S Ou;S Ogino;D Niedzwiecki;L Saltz;R Mayer;R Mowat;R Whittom;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;C Gross;M Irwin;J Meyerhardt;C Fuchs
Journal / Conference
JNCI Cancer Spectrum Apr 12;5(3):pkab034
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID34104867
PMC
PMC8178799
Study Number(s)
C89803

Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/Leucovorin or Epirubicin/Cisplatin/Fluorouracil Before and After Chemoradiation on CALGB (Alliance) 80101

Authors
J Patel;C Jiang;K Owzar;F Mulkey;J Luzum;H Mamon;R Swanson;D Haller;T Dragovich;S Alberts;G Bjarnason;C Willett;D Niedzwiecki;P Enzinger;M Ratain;C Fuchs;H McLeod
Journal / Conference
Pharmacogenetics and Genomics Dec 1;31(9):215-220
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID34149004
PMC
PMC8490297

Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)

Authors
T Haddad;J He;C O'Sullivan;B Chen;D Northfelt;A Dueck;K Ballman;K Tenner;C De Silva;H Linden;E Perez;M Goetz;P Haluska
Journal / Conference
Breast Cancer Research and Treatment Jul;188(2):477-487
Year
2021
Research Committee(s)
Breast
PMID
PMID33852121
PMC
PMC8262517

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

Authors
I Mayer;F Zhao;C Arteaga;WF Symmans;B Park;B Burnette;A Tevaarwerk;S Garcia;K Smith;D Makower;M Block;K Morley;C Jani;C Mescher;S Dewani;B Tawfik;L Flaum;E Mayer;W Sikov;E Rodler;L Wagner;A DeMichele;J Sparano;A Wolff;K Miller
Journal / Conference
Journal of Clinical Oncology, Aug 10;39(23):2539-2551; Jun 6;JCO2100976. doi: 10.1200/JCO.21.00976. Online ahead of print
Year
2021
Research Committee(s)
Breast
PMID
PMID34092112
Study Number(s)
CTSU/EA1131

Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial

Authors
B Tilley;A Mainous;R Amorrorotu;M McKee;D Smith;R Lee;S DeSantis;S Vernon;G Koch;M Ford;V Diaz;J Alvidrez;RECRUIT investigators (J Zell)
Journal / Conference
Contemporary Clinical Trials Oct;109:106519
Year
2021
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID34333138
PMC
PMC8665835
Study Number(s)
S0820

Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years

Authors
J Unger;M Beauchemin;D Hershman
Journal / Conference
Cancer, Dec 15;127(24):4574-4584
Year
2021
Research Committee(s)
Cancer Care Delivery
PMID
PMID34351619
PMC
PMC8665001

E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN Cancer Research Group

Authors
RM Connolly;F Zhao;K Miller;M Lee;R Piekarz;K Smith;U Brown-Glaberman;B Faller;AA Onitilo;M Burkard;GT Budd;E Levine;M Royce;P Kaufman;A Thomas;J Trepel;A Wolff;J Sparano
Journal / Conference
Journal of Clinical Oncology, Oct 1;39(28):3171-3181
Year
2021
Research Committee(s)
Breast
PMID
PMID34357781
PMC
PMC8478386
Study Number(s)
CTSU/E2112

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

Authors
J Unger;H Xiao;M Leblanc;D Hershman;CD Blanke
Journal / Conference
JAMA Network Open, Jul 1;4(7):e2118433. doi: 10.1001/jamanetworkopen.2021.18433
Year
2021
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID34323986
PMC
PMC8323000

Racial Differences in Survival and Response to Therapy in Patients with Metastatic Colorectal Cancer: A Secondary Analysis of CALGB/SWOG 80405 (Alliance A151931)

Authors
R Snyder;J He;J Le-Rademacher;F-S Ou;A Dodge;T Zemla;E Paskett;G Chang;F Innocenti;CD Blanke;H-J Lenz;B Polite;A Venook
Journal / Conference
Journal of Clinical Oncology, Oct 15;127(20):3801-3808
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID34374082
PMC
PMC8478698
Study Number(s)
CTSU/C80405

A Multicenter Phase II Trial (SWOG S1609, Cohort 51) of Ipilimumab and Nivolumab in Metastatic or Unresectable Angiosarcoma: a Sub-Study of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART)

Authors
M Wagner;M Othus;S Patel;C Ryan;A Sangal;B Powers;G Budd;A Victor;C-T Hsueh;R Chugh;S Nair;K Leu;M Agulnik;E Sharon;E Mayerson;M Plets;C Blanke;H Streicher;YK Chae;R Kurzrock
Journal / Conference
Journal for Immunotherapy of Cancer, Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990
Year
2021
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID34380663
PMC
PMC8330584
Study Number(s)
S1609